Riddhi Siddhi Gluco Biols Intrinsic Value
RIDDHI • Commercial Services
Current Stock Price
₹412.60
Primary Intrinsic Value
₹926.40
Market Cap
₹288.8 Cr
+82.8%
Upside
Median Value
₹754.29
Value Range
₹165 - ₹1238
Assessment
Trading Below Calculated Value
Safety Margin
45.3%
RIDDHI Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹926.40 | ₹741.12 - ₹1111.68 | +124.5% | EPS: ₹77.20, Sector P/E: 12x |
| Book Value Method | asset | ₹1031.50 | ₹928.35 - ₹1134.65 | +150.0% | Book Value/Share: ₹2267.14, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹246.86 | ₹222.17 - ₹271.55 | -40.2% | Revenue/Share: ₹308.57, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹754.29 | ₹678.86 - ₹829.72 | +82.8% | EBITDA: ₹88.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹165.04 | ₹132.03 - ₹198.05 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹494.08 | ₹444.67 - ₹543.49 | +19.7% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹636.13 | ₹572.52 - ₹699.74 | +54.2% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹1237.80 | ₹1114.02 - ₹1361.58 | +200.0% | EPS: ₹77.20, BVPS: ₹2267.14 |
Method Types:
Earnings
Asset
DCF
Growth
Dividend
Conservative
Valuation Comparison Chart
RIDDHI Intrinsic Value Analysis
What is the intrinsic value of RIDDHI?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Riddhi Siddhi Gluco Biols (RIDDHI) is ₹754.29 (median value). With the current market price of ₹412.60, this represents a +82.8% variance from our estimated fair value.
The valuation range spans from ₹165.04 to ₹1237.80, indicating ₹165.04 - ₹1237.80.
Is RIDDHI undervalued or overvalued?
Based on our multi-method analysis, Riddhi Siddhi Gluco Biols (RIDDHI) appears to be trading below calculated value by approximately 82.8%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 38.12 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 3.5% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Asset Turnover Ratio | 0.12x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
Related Pages for Riddhi Siddhi Gluco Biols
Additional stock information and data for RIDDHI
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-28 Cr | ₹-28 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹9 Cr | ₹9 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹161 Cr | ₹126 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹130 Cr | ₹104 Cr | Positive Free Cash Flow | 8/10 |